[Nephrotoxicity of aminoglycoside antibiotics].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D005260:Female; D005839:Gentamicins / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014031:Tobramycin / Q000009:adverse effects* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; C001495:bekanamycin; D007612:Kanamycin; D014031:Tobramycin
Nefrotossicità da antibiotici aminoglicosidici.